Methotrexate is the first line of treatment, but targeted drugs such as biological agents (TNF inhibitors, IL-6 inhibitors, B-cell-depleting agents and costimulatory inhibitors) may dramatically improve the different manifestations of RA. The gene discussed is IL6; the disease is rheumatoid arthritis.